Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1293 | 1099 | 1316 | 1132 | 1654 | 3270 |
Fund Return | 29.3% | 9.95% | 31.61% | 4.21% | 10.59% | 12.58% |
Place in category | 274 | 194 | 289 | 1310 | 413 | 26 |
% in Category | 16 | 12 | 17 | 87 | 37 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Div Fund Series D CAD | 22.88B | 21.36 | 10.52 | 8.15 | ||
RBC Canadian Div Fund Series F CAD | 22.88B | 21.66 | 10.83 | 8.46 | ||
RBC Canadian Dividend Fund Series I | 22.88B | 21.94 | 11.11 | 8.76 | ||
RBC Sel Gr Port Sr A CAD | 18.06B | 17.70 | 5.16 | 6.86 | ||
RBC Sel Gr Port Sr F CAD | 18.06B | 18.79 | 6.23 | 7.95 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.18B | 55.54 | 14.87 | - | ||
Mawer Global Equity | 13.9B | 11.93 | 6.20 | 10.88 | ||
Capital Group Glbal Equity Fd F CAD | 14.19B | 27.39 | 5.28 | 11.77 | ||
Capital Group Glbal Equity Fd A CAD | 14.19B | 26.11 | 4.12 | 10.53 | ||
Capital Group Glbal Equity Fd D CAD | 14.19B | 27.03 | 4.93 | 11.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.46 | 439.33 | +0.94% | |
Amazon.com | US0231351067 | 5.43 | 229.05 | +1.77% | |
NVIDIA | US67066G1040 | 5.35 | 140.22 | +0.39% | |
UnitedHealth | US91324P1021 | 4.52 | 506.10 | -0.05% | |
Safran | FR0000073272 | 3.64 | 209.70 | +0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review